Memantine Can Relieve the Neuronal Impairment Caused by Neurotropic Virus Infection

Leqiang Sun,Meiling Zhou,Chuangang Liu,Yajie Tang,Ke Xiao,Jinxia Dai,Zhisong Gao,Leonard Siew,Gang Cao,Xiang Wu,Liang Li,Ran Zhang
DOI: https://doi.org/10.1002/jmv.25396
IF: 20.693
2019-01-01
Journal of Medical Virology
Abstract:Neurotropic viruses, such as the rabies virus (RABV) and Japanese encephalitis virus (JEV), induce neuronal dysfunction and complication, causing neuronal damage. Currently, there are still no effective clinical treatments for neuronal injury caused by neurotropic viruses. Memantine, a drug capable of passing through the blood‐brain barrier, noncompetitively and reversibly binds to n‐methyl‐ d‐aspartic acid (NMDA) receptors. Memantine is used to treat Alzheimer's disease by blocking the activation of extra axonal ion channels, thus preventing neuronal degeneration by inhibiting the abnormal cytosolic Ca 2+ increase. To explore whether memantine can alleviate neurological disturbances caused by RABV and JEV, the following experiments were carried out: (1) for primary neurons cultured in vitro infected with RABV, the addition of memantine showed neuroprotection. (2) In the RABV challenge experiments, memantine had limited therapeutic effect, mildly extending the survival time of mice. In contrast, memantine significantly prolonged the survival time of mice infected with JEV, by reducing the intravascular cuff and inflammatory cell infiltration in mice. Furthermore, memantine decreases the amount of JEV virus in mice brain.
What problem does this paper attempt to address?